查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2008955

神經系統醫療設備市場報告：按產品、最終用戶和地區分類（2026-2034 年）

Neurology Devices Market Report by Product, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球神經醫療設備市場規模達154億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到268億美元，2026年至2034年的複合年成長率（CAGR）為6.20%。推動市場成長的因素多種多樣，包括癲癇、阿茲海默症、失智症和腦血管疾病等各種神經系統疾病的盛行率不斷上升，技術進步帶來的改良型醫療器材的推出，以及老年人口的成長。

神經系統醫療設備市場趨勢：

神經系統疾病盛行率增加

根據世界衛生組織（世衛組織）的數據，2021年全球有2.06億人患有糖尿病神經病變。人們飽受多種神經系統疾病的折磨，這些疾病的原因包括遺傳性疾病、感染疾病、先天缺陷、文明病（如營養不良）以及腦部、脊髓和神經損傷。這些疾病對患者的生活造成負面影響，導致協調能力受損、肌肉無力、感覺障礙等問題。此外，患者對有效可靠解決方案的需求日益成長，推動了神經系統設備的需求。這些設備能夠對大腦活動和結構進行詳細的可視化和監測，從而實現對神經系統疾病的精準診斷。

由於技術進步，改良型設備得以引入

主要企業正致力於推出融合創新技術、能夠改善病患照護的醫療設備。這些企業提供的設備具備遠端醫療患者監測。例如，2022年4月25日，雅培發布了其數位健康應用程式NeuroSphere™ myPath™的新版本。此版本包含多項功能，使醫生能夠更密切地監測患者。在使用背根神經節（DRG）或脊髓刺激（SCS）治療設備時，患者、醫生和醫療團隊可以在治療過程的每個階段，透過該數位健康應用程式共同查看患者報告的療效指標。

老年人口增加

全球老年人口的不斷成長為神經醫療設備市場帶來了光明的前景。老年人由於更容易患上失智症、中風、帕金森氏症和阿茲海默症神經系統疾病，因此對神經醫療設備的需求日益成長。隨著老年人需要更多醫療護理，且神經系統疾病的盛行率也更高，對神經系統服務和醫療用品的需求也不斷增加。世界衛生組織（世衛組織）預測，到2050年，80歲以上人口數將達到4.26億。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 二手資訊
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球神經醫療設備市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品分類

  • 神經刺激設備
  • 神經外科醫療設備
  • 用於介入神經放射學的醫療設備
  • 腦脊髓液管理裝置
  • 其他

第7章 市場區隔：依最終用戶分類

  • 醫院
  • 門診手術中心
  • 神經科診所

第8章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第9章 SWOT 分析

第10章：價值鏈分析

第11章：波特五力分析

第12章：價格分析

第13章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Abbott
    • B. Braun SE
    • Boston Scientific Corporation
    • Integra LifeSciences Corporation
    • LivaNova PLC
    • Medtronic plc
    • Natus Medical Incorporated
    • Nihon Kohden Corporation
    • Penumbra, Inc
    • Stryker Corporation
Product Code: SR112026A6191

The global neurology devices market size reached USD 15.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 26.8 Billion by 2034, exhibiting a growth rate (CAGR) of 6.20% during 2026-2034. There are various factors that are driving the market, which include increasing prevalence of various neurological disorders like epilepsy, Alzheimer's disease, dementias, and cerebrovascular diseases, introduction of improved devices due to technological advancements, and rising geriatric population.

NEUROLOGY DEVICES MARKET ANALYSIS:

  • Major Market Drivers: One of the key market drivers is favorable government initiatives. Moreover, the expansion of healthcare facilities is acting as a growth-inducing factor.
  • Key Market Trends: The market demand is propelled, owing to numerous primary trends, which include rising incidences of various neurological disorders and the increasing geriatric population.
  • Geographical Trends: According to the report, North America exhibits a clear dominance, accounting for the largest market share on account of the presence of advanced healthcare facilities.
  • Competitive Landscape: Some of the major market players in the neurology devices industry are Abbott, B. Braun SE, Boston Scientific Corporation, Integra LifeSciences Corporation, LivaNova PLC, Medtronic plc, Natus Medical Incorporated, Nihon Kohden Corporation, Penumbra, Inc, and Stryker Corporation, among many others.
  • Challenges and Opportunities: One of the key challenges hindering the market growth are regulatory hurdles. On the other hand, advancements in regenerative medicine and restorative therapies represent recent opportunities.

NEUROLOGY DEVICES MARKET TRENDS:

Increasing Prevalence of Neurological Disorders

According to the World Health Organization (WHO), the number of people with diabetic neuropathy was 206 Million in 2021. People are suffering from numerous neurological disorders on account of genetic disorders, infections, congenital abnormalities, lifestyle health problems including malnutrition, and brain, spinal cord, and nerve injury. These diseases have a negative impact on the life of individuals like poor coordination, muscle weakness, and loss of sensation. In addition, the rising need for effective and reliable solutions among patients is catalyzing the neurology device demand. These devices enable precise diagnosis of neurological conditions by allowing detailed visualization and monitoring of brain activity and structure.

Introduction of Improved Devices Due to Technological Advancements

Key players are focusing on introducing devices that have innovative technologies and can provide enhanced care to patients. They are offering devices that have telemedicine capabilities and allow for remote monitoring of patients. For example, Abbott released a new edition of its NeuroSphere TM myPath TM digital health app on 25 April 2022. This version has more features that will allow physicians to monitor their patients more carefully. While using a dorsal root ganglion (DRG) or spinal cord stimulation (SCS) therapy device, the patient, a doctor, and their team can view patient-reported outcome measurements together on a digital health app at every point of the treatment process.

Rising Geriatric Population

The increasing number of geriatric populations across the globe is offering a positive neurology devices market outlook. Owing to their increased vulnerability to neurological conditions such as dementia, stroke, Parkinson's disease, and Alzheimer's disease, older persons are becoming more and more in need of neurology equipment. Elderly people require more medical attention, and as neurological issues are more prevalent in this age group, there is a greater need for neurology services and supplies. The World Health Organization (WHO) projects that the number of persons aged 80 years or older is expected to reach 426 Million in 2050.

NEUROLOGY DEVICES MARKET SEGMENTATION:

Breakup by Product:

  • Neurostimulation Devices
  • Neurosurgery Devices
  • Interventional Neurology Devices
  • Cerebrospinal Fluid Management Devices
  • Others

Neurostimulation devices account for the majority of the market share

Neurostimulation devices play a crucial role in stimulating nerves and regulating faulty neural pathway behavior arising from the disease process by means of medication, electrical signals, or energy. They provide a customized approach to managing the patient's condition and can be adjusted to meet the needs of the individual. Neurostimulation offers an alternative that may reduce the need for medication or dosage for those who depend on it to control their symptoms. Additionally, these tools can help with focus, cognitive enhancement, better sleep, less stress, and treatment of conditions including depression, migraines, anxiety, and insomnia, which is contributing to the neurology devices market growth. Moreover, big players in the market are introducing new products and receiving money from authorities to enhance patient care. For instance, on 08 January 2024, the US FDA approved Medtronic plc's PerceptTM RC deep brain stimulation (DBS) system. The rechargeable neurostimulator is the newest member of the Medtronic PerceptTM family, which also includes the PerceptTM PC neurostimulator, BrainSenseTM technology, and SenSightTM directional leads. Individualized treatment plans can be created for patients with movement disorders such as essential tremor, dystonia, Parkinson's disease, and epilepsy using the only sensing-enabled DBS device in the PerceptTM family.

Breakup by End User:

  • Hospitals
  • Ambulatory Surgery Centers
  • Neurology Clinics

Hospitals hold the largest share of the industry

In 2021, there were approximately 165,000 hospitals worldwide, according to DiscoveryABATherapy. Hospitals are outfitted to offer full medical care, including sophisticated neurological disorder treatments, emergency services, and advanced diagnostics. As a result, they serve as the main locations for the use of various neurology devices. Furthermore, hospitals can accommodate a greater number of patients including those with neurological disorders as compared to other types of healthcare institutions. The need for neurology equipment in these settings is driven by the increased patient influx. These facilities also feature the infrastructure required to handle advanced neurological devices, as well as specialist medical personnel like neurologists, neurosurgeons, and specialized nursing care. This includes wards designed specifically for post-operative care and monitoring and operating rooms furnished for neurosurgery procedures.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest neurology devices market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for neurology devices.

North America has modern medical technologies with state-of-the-art healthcare institutions. The region's medical research institutes are concentrating on research and development (R&D) endeavors, as these operations foster innovation and lead to the release of new neurological equipment onto the market. Apart from this, the market expansion is being aided by favorable government efforts in North America. Moreover, the high prevalence of neurological disorders among the North American population necessitates robust healthcare solutions. The need for neurology equipment in the region is fueled by their vital role in the management and treatment of various illnesses. As per the Alzheimer's Association, there were will be around13 Million Americans that will suffer from Alzheimer's disease by 2050.

Competitive Landscape:

Top companies in neurology devices industry are forming strategic mergers and acquisitions (M&As), partnerships, and collaborations to expand their product portfolios and geographical reach. They are creating novel and inventive products with improved efficacy and safety by investing in R&D activities. Additionally, companies are expanding their operations globally to tap into emerging markets where there is a growing awareness of neurological diseases and an increasing capability to spend on advanced medical treatments. This includes establishing production facilities or sales offices in new areas, which will also benefit in increasing their neurology devices market revenue. To remain competitive in the market, they are also launching new items and updating old ones. For instance, Abbott introduced its NeuroSphereTM Virtual Clinic in the United States on 8 March 2021. This innovative technology enables patients to interact with doctors, guarantee optimal settings and functionality, and obtain new treatment settings from a distance. Approved by the U.S. Food and Drug Administration (FDA), the NeuroSphere Virtual Clinic can increase access to optimal treatment for patients suffering from chronic pain or movement disorders.

The report provides a comprehensive analysis of the competitive landscape in the global neurology devices market with detailed profiles of all major companies, including:

  • Abbott
  • B. Braun SE
  • Boston Scientific Corporation
  • Integra LifeSciences Corporation
  • LivaNova PLC
  • Medtronic plc
  • Natus Medical Incorporated
  • Nihon Kohden Corporation
  • Penumbra, Inc
  • Stryker Corporation

KEY QUESTIONS ANSWERED IN THIS REPORT

1. What was the size of the global neurology devices market in 2025?

2. What is the expected growth rate of the global neurology devices market during 2026-2034?

3. What are the key factors driving the global neurology devices market?

4. What has been the impact of COVID-19 on the global neurology devices market?

5. What is the breakup of the global neurology devices market based on the product?

6. What is the breakup of the global neurology devices market based on the end user?

7. What are the key regions in the global neurology devices market?

8. Who are the key players/companies in the global neurology devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Neurology Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Neurostimulation Devices
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Neurosurgery Devices
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Interventional Neurology Devices
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Cerebrospinal Fluid Management Devices
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by End User

  • 7.1 Hospitals
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Ambulatory Surgery Centers
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Neurology Clinics
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abbott
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 B. Braun SE
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 SWOT Analysis
    • 13.3.3 Boston Scientific Corporation
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Integra LifeSciences Corporation
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 LivaNova PLC
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
    • 13.3.6 Medtronic plc
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
      • 13.3.6.4 SWOT Analysis
    • 13.3.7 Natus Medical Incorporated
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Nihon Kohden Corporation
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Penumbra, Inc
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
    • 13.3.10 Stryker Corporation
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Neurology Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Neurology Devices Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Neurology Devices Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Neurology Devices Market: Breakup by Product (in %), 2025
  • Figure 5: Global: Neurology Devices Market: Breakup by End User (in %), 2025
  • Figure 6: Global: Neurology Devices Market: Breakup by Region (in %), 2025
  • Figure 7: Global: Neurology Devices (Neurostimulation Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 8: Global: Neurology Devices (Neurostimulation Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 9: Global: Neurology Devices (Neurosurgery Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Neurology Devices (Neurosurgery Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Neurology Devices (Interventional Neurology Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Neurology Devices (Interventional Neurology Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Neurology Devices (Cerebrospinal Fluid Management Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Neurology Devices (Cerebrospinal Fluid Management Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Neurology Devices (Other Products) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Neurology Devices (Other Products) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Neurology Devices (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Neurology Devices (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Neurology Devices (Ambulatory Surgery Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Neurology Devices (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Neurology Devices (Neurology Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Neurology Devices (Neurology Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: North America: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: North America: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: United States: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: United States: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Canada: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Canada: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Asia-Pacific: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Asia-Pacific: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: China: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: China: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Japan: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Japan: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: India: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: India: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: South Korea: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: South Korea: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Australia: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Australia: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Indonesia: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Indonesia: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Others: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Others: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Europe: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Europe: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Germany: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Germany: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: France: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: France: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: United Kingdom: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: United Kingdom: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Italy: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Italy: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Spain: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Spain: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Russia: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Russia: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Others: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Others: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Latin America: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Latin America: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Brazil: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Brazil: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Mexico: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Mexico: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Others: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Others: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Middle East and Africa: Neurology Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Middle East and Africa: Neurology Devices Market: Breakup by Country (in %), 2025
  • Figure 71: Middle East and Africa: Neurology Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Global: Neurology Devices Industry: SWOT Analysis
  • Figure 73: Global: Neurology Devices Industry: Value Chain Analysis
  • Figure 74: Global: Neurology Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Neurology Devices Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Neurology Devices Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Neurology Devices Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 4: Global: Neurology Devices Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 5: Global: Neurology Devices Market: Competitive Structure
  • Table 6: Global: Neurology Devices Market: Key Players